Geriatric Nursing
Volume 27, Issue 2 , Pages 77-82 , March 2006

Management of Diabetes Mellitus in Older Persons

References 

  1. Prevalence of diabetes in 500,000 residents of long-term care facilities in the United States, proprietary administrative data . Covington, KY: Omnicare; 2004;
  2. Haines ST . The diabetes epidemic (can we stop the spread?) . Pharmacother . 2003;23:1227–1231
  3. Travis SS , Buchanan RJ , Wang S , et al.   Analyses of nursing home residents with diabetes at admission . J Am Med Dir Assoc . 2004;4:320–327
  4. American Diabetes Association . Standards of medical care in diabetes . Diabetes Care . 2005;28: S4-S79
  5. American Geriatric Society . Guidelines for improving the care of the older person with diabetes mellitus . JAGS . 2003;51: S265-80
  6. American Medical Directors Association . Managing diabetes in the long-term care setting (clinical practice guideline) . Columbia, MD: American Medical Directors Association; 2002;
  7. UK Prospective Diabetes Study Group . Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) . Lancet . 1998;332:837–853
  8. Lewis EJ , Hunsicker LG , Clarke WR , et al.   Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes . N Engl J Med . 2001;345:851–860
  9. Parving HH , Lehnert H , Brochner-Mortensen J , et al.   The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes . N Engl J Med . 2001;345:870–878
  10. Brenner BM , Cooper ME , de Zeeuw D , et al.   Effects of losartan on renal and cardiovascular outcomes in patients with Type 2 diabetes and nephropathy . N Engl J Med . 2001;345:861–869
  11. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VII). National Heart, Lung and Blood Institute, National Institute of Health, U.S. Department of Health and Human Services. August 2004. Available at: www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Cited July 17, 2005
  12. Ramlo-Halsted BA , Edelman SV . The natural history of type 2 diabetes (practical points to consider in developing prevention and treatment strategies) . Clinical Diabetes . 2000;18:80–85
  13. Kirplchnikov D , McFarlane SI , Sowers JR . Metformin (an update) . Ann Intern Med . 2002;137:25–33
  14. DeFronzo R . Pharmacologic therapy for type 2 diabetes . Ann Intern Med . 1999;17:281–303
  15. Nesto RW , Bell D , Bonow RO , et al.   Thiazolidinedione use, fluid retention, and congestive heart failure. A consensus statement from the American Heart Association and American Diabetes Association . Diabetes Care . 2004;27:256–263
  16. Hay LC , Wilmshurst EG , Fulcher G . Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus (the results of continuous glucose monitoring) . Diabetes Technol Therap . 2003;5:19–26
  17. Carroll MF , Gutierrez A , Castro M , Tsewang D , Schade DS . Targeting postprandial hyperglycemia (a comparative study of insulinotropic agents in type 2 diabetes) . J Clin Endocrinol Metab . 2003;88:5248–5254
  18. Del Prato S , Heine RJ , Keilson L , et al.   Treatment of patients over 64 years of age with type 2 diabetes. Experience from nateglinide pooled database retrospective analysis . Diabetes Care . 2003;26:2075–2080
  19. Yki-Jarvinen H , Dressler A , Ziemen M . Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes . Diabetes Care . 2000;23:1130–1136
  20. Hay LC , Wilmshurst EG , Fulcher G . Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus (the results of continuous glucose monitoring) . Diabetes Technol Ther . 2003;5:19–26
  21. Krepinsky J , Ingram AJ , Clase CM . Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with end-stage renal disease . Am J Kid Dis . 2000;35:500–505
  22. Juurlink DN , Mamdani M , Kopp A , et al.   Drug-drug interactions among elderly patients hospitalized for drug toxicity . JAMA . 2003;289:1652–1658

PII: S0197-4572(06)00061-9

doi: 10.1016/j.gerinurse.2006.02.001

Geriatric Nursing
Volume 27, Issue 2 , Pages 77-82 , March 2006

Article Tools

* Image Usage & Resolution